We are excited to be sponsoring and speaking at the Advanced Therapies Europe 2026 in Barcelona, Spain this September.
Advanced Therapies Europe is a focused conference and networking event for the advanced therapies and regenerative medicine community. It brings together key people across European biotech and life sciences to discuss innovation, investment and bringing new treatments to market.
Hear live from Cell and Gene Therapy Catapult.
Panel: Europe’s Roadmap Winning the Next Wave of ATMP R&D: What Europe must resolve to compete on speed, scale and return
Speed breaks first: Why Europe still loses ATMP programmes at the trial-start and scale-up stages and what can be fixed in the next 12 months around approvals, site readiness and cross-border trial execution.
Scale without fragmentation: How disjointed manufacturing capacity, inconsistent incentives and weak CDMO coordination slow R&D momentum and what more joined-up European models could unlock faster progression from clinic to commercial.
Return signals matter: How reimbursement uncertainty, grant complexity and IP anxiety dilute investor confidence and which policy and payer signals would materially improve Europe’s risk-reward profile for ATMP R&D.
Where innovation leaks out: Identifying the points where advanced therapies quietly leave Europe (post-Phase I/II, before pivotal trials, pre-commercial scale-up) and how to retain them without protectionism.
Speaker: Jacqueline Barry, Chief Clinical Officer
Date and time: 08 September 2026, 09:50 - 10:30
Location: Theatre 1&2 (Rubi & Zafir)